# Study of Botulinum Toxin and Recovery of Hand Function After Stroke

> **NCT01422161** · PHASE3 · COMPLETED · sponsor: **NYU Langone Health** · enrollment: 16 (actual)

## Conditions studied

- Stroke With Hemiparesis

## Interventions

- **DRUG:** Botulinum Toxin commonly known as BOTOX®
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01422161
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2015-10
- **Final completion:** 2015-10
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2019-06-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01422161

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01422161, "Study of Botulinum Toxin and Recovery of Hand Function After Stroke". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01422161. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*